5-BROMO-2,3-DIHYDRO-1H-INDENE-1-CARBONITRILE, 95.0%, 1g

2-CHLORO-4-((2,5-DIMETHYL-1-(4-(TRIFLUOROMETHOXY)PHENYL)-1H-IMIDAZOL-4-YL)ETHYNYL)PYRIDINE, 95%, 5mg

3-Hydroxybenzaldehyde, min. 97%, for synthesis, 50 g, plastic packaging.

Cyclothiazide (mixture of isomers)>95.0%(HPLC)25mg

Tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione, 95.0%, 250mg

(S)-2-(Piperidin-2-yl)ethanol, 95.0%, 100mg

(3-Amino-4-chlorophenyl)methanol, 97%, 25g

Dimethoxy(methyl)silane>97.0%(GC)100mL

3,5-dibromo-1-[2-(1,3-dioxan-2-yl)ethyl]-1H-1,2,4-triazole, 95.0%, 1g

2-[(3-Fluorophenyl)thio]ethanol, 98.0%, 1g

1-BOC-3,3-DIFLUORO-4-HYDROXYPYRROLIDINE, 95.0%, 1g

tert-Butyl 3-Methylenecyclobutylcarbamate, 95.0%, 5g

(2,6-Dimethoxyphenyl)methanol, 95.0%, 10g